Dosing our first patient in the VAN-2401 phase 1 trial is an important milestone in the advancement of KH658 by exploring the ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

The phase 2 clinical trial data evaluating the efficacy, safety, and dosing intervals of high-dose IBI302 were presented during the annual 2025 ARVO meeting. Innovent Biologics recently announced its ...

Jennifer Lim, MD, FARVO, FASRS, discusses her ARVO presentation on sickle cell retinopathy, highlighting improvements in retinal surgery techniques and instrumentation. Joining the Eye Care Network in ...

The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on the US market for use in clinics and healthcare institutions. The US Food ...

The Retinal Genix plans to use the facility to further the development of its DNA/RNA/GPS Pharmaco-Genetic Mapping platform. RetinalGenix has signed a new laboratory lease agreement with life science ...

In an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab. At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, ...

Preclinical data on the use of Purified Cortrophin Gel (repository corticotropin injection USP) was recently announced by ANI Pharmaceuticals. 1 Cotrophin Gel is a prescription injection indicated for ...